Publication for Cd163 and Lyve1
| Species | Symbol | Function* | Entrez Gene ID* | Other ID | Gene coexpression |
CoexViewer |
|---|---|---|---|---|---|---|
| mmu | Cd163 | CD163 antigen | 93671 | [link] | ||
| mmu | Lyve1 | lymphatic vessel endothelial hyaluronan receptor 1 | 114332 |
| Pubmed ID | Priority | Text |
|---|---|---|
| 29262593 | 0.98 | Lyve-1 derived from macrophage-like cells significantly decreases melanoma cell proliferation by functioning as a decoy receptor for LMW-HA even though LYVE-1+ macrophages display a M2-like phenotype with a strong co-expression of the M2-markers CD206 and CD163. |
| 0.98 | LYVE-1+ TAMs has already been described by others in TS/A tumors: Lyve-1 was differentially expressed in a subpopulation of macrophages displaying high expression of Arg-1, CD206, CD163 and Stab-1. | |
| 0.95 | LYVE-1 expressing TAM are however true M2 macrophages as they co-express typical M2-markers such as CD163 and CD206. | |
| 0.89 | LYVE-1 expression was detected only in a subpopulation comprising approximately 25 % of the MDI-treated pBM (Figure 3D-3E), which showed even higher expression levels of CD163 and CD206 (Figure 3F). | |
| 22590615 | 0.98 | CD163, and Lyve-1. |
| 0.97 | Lyve-1, Cxcl1, Mmp13, Cxcl2, Pf4, Cd163, Cxcl3, Il10, Tnfsf9, Mrc1, Vsig4, and Colec12) have previously-identified immunological functions. | |
| 0.54 | Lyve-1, Cxcl1, Mmp13, Cxcl2, Cbr1, CD163 and Emp1. | |
| 29521008 | 0.98 | Lyve1, MafB, and CD163 and a concomitant decrease in MHCII and Ym1 relative to F+/V- macrophages across the board, consistent with their identity as a distinct, monocyte-derived macrophage subset. |
| 0.98 | CD163 confirms the monocytic origin and Lyve1 denotes these macrophages as TAMs. | |
| 0.88 | Lyve1, MafB, and CD163. | |
| 30538339 | 0.98 | Lyve1, Timd4, Retnla, Cd163, Folr2 and Klf2) were down-regulated, while genes associated with monocytes (Ms4a7 and Spp1) were up-regulated in post-infarct macrophages compared to non-infarct control macrophages (Fig. 5f). |
| 0.98 | LYVE1, CD163, FOLR2, IGF1 and MAF (Supplementary Fig. 5c). | |
| 22231304 | 0.98 | CD163, FXIIIa1, and Lyve1, which have been previously associated with MPs involved in wound healing or tissue repair. |
| 25024137 | 0.98 | CD163, LYVE-1, Arg1, Clec10a (CD301), Chi3L3, and CD206 (mannose receptor, Mrc1; Fig. 2 A and Table S1), as well as mRNA for MARCO, which is associated with innate macrophage activation. |
| 28920002 | 0.98 | CD163, Fc receptor-like S (Fcrls), stabilin 1 (Stab1), mannose receptor (Mrc1), and other M2TAM markers and secreted proteins, including lymphatic vessel endothelial hyaluronan receptor 1 (Lyve1), and coagulation factor XIII A subunit (F13a1) (Fig. 7C). |
| 20185806 | 0.97 | CD163, and LYVE-1 (Fig. 3) and was three times more likely than other eATMPhi subtypes to stain for the IB4 isolectin (data not shown), a marker of adipogenic and angiogenic activities in eAT of obese mice. |
| 0.95 | CD163, LYVE-1, and PPAR-alpha). | |
| 22271661 | 0.97 | CD163 and Lyve1 (P <= 0.005 and P <= 0.05, respectively) and a trend towards upregulation of Arg1, Igf1 and Tie2, compared with CD11c+/CD206- (M1-like) macrophages (Supplementary Fig. 8). |
| 30382198 | 0.95 | Lyve1 and Cd163. |
| 23130156 | 0.94 | CD163-positive cells were costained with an anti-LYVE-1 mAb, M2 macrophages seemed to serve as lymphatic endothelial progenitor cells. |
| 30092836 | 0.93 | CD163+ cells expressed genes recently identified in BAMs of the mouse brain, such as Mrc1 (CD206), Mertk, Adgre1 (F4.80), Fcgr3a (CD16), C5ar1 (CD88), Lyve1, RT1-ba (MHC class II antigen), Cd44, Cd38, and Tmem119, Csf1r, and Cxcr4. |
| 31481690 | 0.91 | Cd163, folate receptor beta precursor (Folr2) and lymphatic endothelium hyaluronan receptor-1 (Lyve1) in Cluster 2; and transcripts encoding angiotensin-converting enzyme (Ace) and low affinity immunoglobulin gamma Fc region receptor IV (Fcgr4, encoding CD16.2) in Cluster 4 (Fig. 1d, and Supplementary Fig. 4c). |
The preparation time of this page was 0.0 [sec].
